1. Home
  2. SCLX vs MATH Comparison

SCLX vs MATH Comparison

Compare SCLX & MATH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Scilex Holding Company

SCLX

Scilex Holding Company

HOLD

Current Price

$19.15

Market Cap

139.3M

Sector

Health Care

ML Signal

HOLD

Logo Metalpha Technology Holding Limited

MATH

Metalpha Technology Holding Limited

HOLD

Current Price

$2.84

Market Cap

145.4M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
SCLX
MATH
Founded
2011
2015
Country
United States
Hong Kong
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Finance/Investors Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
139.3M
145.4M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
SCLX
MATH
Price
$19.15
$2.84
Analyst Decision
Hold
Analyst Count
1
0
Target Price
N/A
N/A
AVG Volume (30 Days)
122.8K
112.5K
Earning Date
11-14-2025
12-05-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.41
Revenue
$40,360,000.00
$44,567,257.00
Revenue This Year
N/A
N/A
Revenue Next Year
$749.70
N/A
P/E Ratio
N/A
$6.93
Revenue Growth
N/A
165.86
52 Week Low
$3.60
$0.88
52 Week High
$34.27
$4.17

Technical Indicators

Market Signals
Indicator
SCLX
MATH
Relative Strength Index (RSI) 51.13 47.36
Support Level $18.34 $2.68
Resistance Level $20.62 $3.03
Average True Range (ATR) 2.22 0.21
MACD -0.02 0.01
Stochastic Oscillator 32.91 49.28

Price Performance

Historical Comparison
SCLX
MATH

About SCLX Scilex Holding Company

Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for relieving pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.

About MATH Metalpha Technology Holding Limited

Metalpha Technology Holding Ltd is a digital asset focused wealth management company. The company predominantly generates revenue from the execution of cryptocurrency-related transactions, which includes the issuance of derivative products to over-the-counter (OTC) clients and its proprietary trading activities. It has partnered with a crypto exchange to provide crypto derivative market-making services for its clients, facilitating the trading of crypto derivative products. In addition, the company also engages in providing traditional financial derivative products, and asset management services. It operates in a single segment which is the trading of proprietary digital assets and derivative contracts, and generates majority of its revenue from Hong Kong.

Share on Social Networks: